Drawing for OPTIHEALTH

USPTO serial 77498364

OPTIHEALTH

Reviewed by CopyMark Law Group

Status 605
Filing date
Status date
Registration date
—
Examiner
DAHLING, KRISTIN M
Law office
OFFICE OF TRADEMARK PROGRAM CONTROL

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with OPTIHEALTH?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Charles M Atkinson

CHARLES M ATKINSON GLAXOSMITHKLINE709 SWEDELAND RDKING OF PRUSSIA, PA 19406-2711UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
003Facial masksABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 4, 2008MAB5ABANDONMENT NOTICE MAILED - AFTER PUBLICATION—
Nov 4, 2008ABN5ABANDONMENT - AFTER PUBLICATION—
Nov 4, 2008PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 15, 2008NPUBNOTICE OF PUBLICATION—
Sep 30, 2008EXARTEAS EXPRESS ABANDONMENT RECEIVED—
Sep 29, 2008PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Sep 29, 2008ALIEASSIGNED TO LIE—
Sep 18, 2008CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 18, 2008DOCKASSIGNED TO EXAMINER—
Jun 18, 2008MPMKNOTICE OF PSEUDO MARK MAILED—
Jun 17, 2008NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance